Download Files:
Carbidopa
$46 – $144
Products Details
Product Description
– Carbidopa ((S)-(-)-Carbidopa), a peripheral decarboxylase inhibitor, can be used for the research of Parkinson’s disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth[1][2].
Web ID
– HY-B0311
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C10H14N2O4
References
– [1]Safe S. Carbidopa: a selective Ah receptor modulator (SAhRM). Biochem J. 2017;474(22):3763-3765. Published 2017 Nov 6.|[2]Fermaglich J. Treatment of Parkinson’s disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa. Med Ann Dist Columbia. 1974;43(12):587-591.
CAS Number
– 28860-95-9
Molecular Weight
– 226.23
Compound Purity
– 98.0
SMILES
– OC1=C(O)C=CC(CC(NN)(C(O)=O)C)=C1
Clinical Information
– Launched
Research Area
– Cancer; Neurological Disease
Solubility
– DMSO : 10 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL
Target
– Aryl Hydrocarbon Receptor
Pathway
– Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
